The Rapid Response™ COVID-19 Antigen Nasal Pen Test is a rapid in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleocapsid protein antigens from nasal secretions within seven (7) days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection. This test is authorized for use at the Point of Care i.e., in patient care setting.
- Test device individually packaged in a foil pouch:
- Pen containing test strip and collection tip
- Pen cap containing sealed compartment with liquid (extraction buffer)
- Product insert
The Rapid Response™ COVID-19 Antigen Nasal Pen Test is a rapid in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleocapsid protein antigens from nasal secretions within seven (7) days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection. This test is authorized for use at the Point of Care i.e., in patient care setting.
- Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
- The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
- Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.
Canada